![[Original Supplier] Regenovue Fine - HA Dermal Filler](https://web.tradekorea.com/product/283/2098283/Regenovue_Fine_-_HA_Dermal_Filler_-_Original_Manufacturer_2.JPG)
[Original Supplier] Regenovue Fine - HA Dermal Filler
HA dermal filler without lido. CE Approved. Made in Korea. Brought to you by the original manufacturer - NeoGenesis Co., Ltd.
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- South Korea
- Brand name
- Regenovue
- Payment Terms
- Others,T/T
- Production method
- Available
- Shipping / Lead Time
- Negotiable / Negotiable
NeoGenesis Co., Ltd.
- Membership
- VIP
- Recent Visit
- Dec 12, 2024
- Country / Year Established
-
South Korea
/
2012
- Business type
- Distributor
- Verified Certificate
-
9
| Product name | [Original Supplier] Regenovue Fine - HA Dermal Filler | Certification | CE |
|---|---|---|---|
| Category |
Other Personal Care
Beauty Equipment Medical Consumables Other Beauty Equipment Other Medical Consumables |
Ingredients | CROSSLINKED HYALURONIC ACID |
| Keyword | hyaluronic acid filler , korean filler , ce filler , monophasic filler | Unit Size | 19.5 * 3.0 * 7.2 cm |
| Brand name | Regenovue | Unit Weigh | 51 g |
| origin | South Korea | Stock | 0 |
| Supply type | Available | HS code | - |
Product Information
Regenovue Fine
Korean HA Dermal Filler Without Lido (Lido Free)
- Cross-linked High Quality Hyaluronic Acid Dermal Filler
- Suitable for Patients Allergic to Lido
- 1ml x 1 syringe per box
- CE Certified
.
.
.
Application Areas of Regenovue Fine
- Superficial wrinkles:
Periorbital lines
Glabellar lines
Perioral lines
Worry lines
.
.
.
< Product Strengths >
- 100% cross-linked with BDDE for no side effects
- Natural volumizing & precise contouring from unique monophasic cross-linking technique
- Consistent injecting pressure for doctors enabling exquisite treatment
- Smooth and relatively less painful injection
- No migration or deformation with up to 45% higher visco-elasticity than competition
- Long-lasting volume which lasts up to 18 months
- Pure non-animal based hyaluronic acid, providing safety from immune response and infections
- High viscosity
- High hydrophilicity
- Competitive market price
.
.
.
< Product Specifications >
- Ingredients: Cross-linked HA 24mg/ml (Main Ingredient), Phosphate-buffered Saline (Additive)
- Injection Depth: Upper Dermis
- Syringe Volume: 1ml x 1 per box
- Needle Size: 30G
- Duration: 8-12 Months
- Storage: Store at 2-25°C away from direct sunlight
- Expiration: 24 Months
- Contents: 1 Syringe & 30G Needle & 27G Needle
- Certifications: ISO 13485, GMP, KFDA, CE
- Country of Manufacture: South Korea
.
.
.
< Other Available Models >
- Regenovue Fine Plus: Same model with lido for superficial wrinkle treatment
- Regenovue Deep / Deep Plus: For middle-deep wrinkle treatment
- Regenovue Sub-Q / Sub-Q Plus: For deep wrinkle treatment & facial augmentation
.
.
.
Regenovue Video Link: https://youtu.be/L42ENPHj2nc
Information also available on our website: http://www.neogenesis.co.kr/eng/item.php?it_id=1646384885
.
.
.
Contact us now for a sample order!
(Website) http://www.neogenesis.co.kr
(YouTube) https://www.youtube.com/@NeogenesisInfo/videos
(Facebook) http://www.facebook.com/neogenesis.coltd
(Twitter) twitter.com/neogenesiscoltd
(Tel) +82-2-583-1348
(FAX) +82-2-2038-0848
(Address) #302, E&C Dream Tower, 146, Seonyu-ro,
Yeongdeungpo-gu, Seoul, South Korea (07255)
.
.
.
- Verified Certificate
-
B2B Trade
| Price (FOB) | Negotiable | transportation | Air Transportation,Express,Land Transportation,Negotiation Other,Ocean Shipping |
|---|---|---|---|
| MOQ | Negotiable | Leadtime | Negotiable |
| Payment Options | Others,T/T | Shipping time | Negotiable |
NeoGenesis Co., Ltd.
- Country / Year Established
-
South Korea
/
2012
- Membership
- VIP
- Recent Visit
- Dec 12, 2024
- Business type
- Distributor
-
9
- President
- Yongpil Kim
- Address
- #302 E&C Dream Tower, 146 Seonyu-ro, Yeongdeungpo-gu, Seoul, Korea
- Product Category
- Makeup,Medical Devices
- Year Established
- 2012
- Company introduction
-
As an enterprise specializing in autologous cell therapy, NeoGenesis develops and exports medical devices to the global market.
-
Since our foundation in 2012, we at NeoGenesis have strived to research and develop innovative medical devices. With expertise in the autologous cell therapy field, we provide our medical devices to not only the domestic market, but also to the global market including the Americas, Europe, Asia, and Africa.
-
We have made efforts to supply knowledge of modern cell therapy through participation in seminars, exhibitions, and training around the world, and now contribute to the global beauty industry as well.
-
NeoGenesis will continue to provide safety and quality guaranteed medical devices and pharmaceuticals, striving for the convenience, satisfaction, and trust that our users and patients rightfully deserve.
- Main Markets
-
Australia
China
Germany
India
Poland
Spain
Turkey
U.S.A
- Main Product
_2.JPG "TRY")
